av/altamira-therapeutics--big.svg

NASDAQ:EARS

Altamira Therapeutics Ltd.

  • Stock

USD

Last Close

0.91

30/08 20:00

Market Cap

2.89M

Beta: 1.40

Volume Today

37.01K

Avg: 1.89M

PE Ratio

−0.05

PFCF: −0.22

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
3.01M
-
-67K
102.23%
-414K
517.91%
322K
177.78%
1.27M
293.17%
-56K
104.42%
174.47K
411.56%
63.88K
63.39%
305.62K
378.41%
cost of revenue
2.24M
-
1.44M
35.56%
gross profit
3.01M
-
-67K
102.23%
-414K
517.91%
322K
177.78%
1.27M
293.17%
-56K
104.42%
174.47K
411.56%
-2.18M
1,347.56%
-1.14M
47.71%
selling and marketing expenses
199.48K
-
113.96K
-
95.66K
16.05%
1.50M
1,466.14%
2.38M
58.95%
15.35K
99.36%
general and administrative expenses
1.31M
-
4.49M
241.94%
4.34M
3.27%
5.41M
24.65%
5.15M
4.84%
4.26M
17.20%
3.93M
7.75%
2.59M
34.04%
4.90M
88.69%
3.52M
28.06%
3.09M
12.19%
selling general and administrative expenses
1.31M
-
4.49M
241.94%
4.34M
3.27%
5.41M
24.65%
5.15M
4.84%
4.26M
17.20%
3.93M
7.75%
2.59M
34.04%
6.39M
146.43%
5.90M
7.68%
3.12M
47.09%
research and development expenses
13.25M
-
17.70M
33.58%
26.54M
49.89%
24.78M
6.63%
19.21M
22.46%
6.69M
65.18%
3.33M
50.29%
2.86M
13.90%
8.94M
212.23%
19.68M
120.13%
3.04M
84.57%
other expenses
49.42K
-
73.43K
48.60%
62.20K
15.30%
34.05K
45.25%
87.59K
157.21%
215.72K
146.28%
-409.93K
-
-586.73K
43.13%
cost and expenses
14.62M
-
22.19M
51.84%
30.88M
39.13%
30.22M
2.12%
24.36M
19.40%
10.95M
55.03%
7.26M
33.73%
5.46M
24.82%
17.16M
214.49%
26.44M
54.04%
6.54M
75.26%
operating expenses
14.62M
-
22.19M
51.84%
30.88M
39.13%
30.22M
2.12%
24.36M
19.40%
10.95M
55.03%
7.26M
33.73%
5.46M
24.82%
14.92M
173.44%
24.99M
67.49%
6.54M
73.83%
interest expense
50.18K
-
49.63K
1.08%
8K
83.88%
828.55K
10,256.84%
1.64M
97.98%
1.07M
34.76%
28.63K
97.32%
135.15K
372.09%
189.69K
40.36%
911.87K
380.70%
ebitda
-14.51M
-
-22.19M
52.98%
-30.84M
38.97%
-30.06M
2.54%
-24.31M
19.13%
-10.95M
54.94%
-7.24M
33.89%
-5.28M
27.04%
-17.02M
222.18%
-26.01M
52.83%
-1.35M
94.80%
operating income
-14.62M
-
-22.19M
51.85%
-30.88M
39.13%
-30.22M
2.12%
-24.36M
19.40%
-10.95M
55.03%
-7.26M
33.73%
-5.28M
27.22%
-17.10M
223.67%
-26.13M
52.82%
-5.92M
77.36%
depreciation and amortization
37.52K
-
73.98K
97.20%
92.78K
25.40%
97.60K
5.20%
122.78K
25.80%
72.71K
40.78%
17.88K
75.41%
258
98.56%
79.58K
30,743.41%
119.86K
50.62%
5.92M
4,836.01%
total other income expenses net
-104.30K
-
3.19M
3,158.33%
1.14M
64.14%
190.95K
83.31%
1.52M
696.45%
690.08K
54.62%
433.41K
37.19%
-2.94M
777.95%
-268.75K
90.85%
-406.26K
51.17%
-1.35M
233.27%
income before tax
-14.70M
-
-18.18M
23.72%
-29.70M
63.35%
-30.79M
3.66%
-24.43M
20.67%
-11.33M
53.60%
-6.83M
39.78%
-8.22M
20.45%
-17.37M
111.26%
-26.54M
52.80%
-7.27M
72.61%
income tax expense
305.75K
-
-892.18K
391.80%
-84.78K
90.50%
-131.06K
54.59%
-17.77K
86.44%
162.18K
1,012.49%
-193.84K
219.52%
-21.28K
89.02%
21.62K
201.58%
-10.33K
147.78%
-1.35M
13,008.13%
net income
-15.00M
-
-18.18M
21.20%
-29.70M
63.35%
-30.66M
3.22%
-24.41M
20.39%
-11.50M
52.90%
-6.63M
42.31%
-8.20M
23.65%
-17.39M
112.07%
-26.53M
52.55%
-7.27M
72.60%
weighted average shs out
4.51K
-
6.92K
53.40%
8.07K
16.63%
8.58K
6.29%
10.94K
27.42%
39.75K
263.53%
145.45K
265.90%
300.71K
106.74%
662.31K
120.25%
910.72K
37.51%
491.26K
46.06%
weighted average shs out dil
4.51K
-
6.92K
53.40%
8.07K
16.63%
8.58K
6.29%
10.94K
27.42%
39.75K
263.53%
145.45K
265.90%
300.71K
106.74%
662.31K
120.25%
910.72K
37.51%
491.26K
46.06%
eps
-3.32K
-
-2.63K
20.99%
-3.68K
40.06%
-3.57K
2.89%
-2.23K
37.52%
-289.20
87.04%
-45.60
84.23%
-27.27
40.20%
-26.26
3.70%
-29.13
10.93%
-14.80
49.19%
epsdiluted
-3.32K
-
-2.63K
20.99%
-3.68K
40.06%
-3.57K
2.89%
-2.23K
37.52%
-289.20
87.04%
-45.60
84.23%
-27.27
40.20%
-26.26
3.70%
-29.13
10.93%
-14.80
49.19%

All numbers in USD (except ratios and percentages)